IBDEI15V ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,536,0)
 ;;=EXPOSURES^5^45
 ;;^UTILITY(U,$J,358.4,537,0)
 ;;=IMMUNIZATIONS^6^45
 ;;^UTILITY(U,$J,358.4,538,0)
 ;;=CARDIOVASCULAR EXERCISE^2^45
 ;;^UTILITY(U,$J,358.4,539,0)
 ;;=COUNSELING^3^45
 ;;^UTILITY(U,$J,358.4,540,0)
 ;;=MUSCLE CONDITIONING EXERCISE^8^45
 ;;^UTILITY(U,$J,358.4,541,0)
 ;;=HEAD AND NECK-MISCELLANEOUS^1^46
 ;;^UTILITY(U,$J,358.4,542,0)
 ;;=NOSE AND SINUSES^3^46
 ;;^UTILITY(U,$J,358.4,543,0)
 ;;=ORAL CAVITY^4^46
 ;;^UTILITY(U,$J,358.4,544,0)
 ;;=OTOLOGY^5^46
 ;;^UTILITY(U,$J,358.4,545,0)
 ;;=PHARYNX AND LARYNX^6^46
 ;;^UTILITY(U,$J,358.4,546,0)
 ;;=MISCELLANEOUS PROCEDURES^2^46
 ;;^UTILITY(U,$J,358.4,547,0)
 ;;=PROLONGED CLINICAL STAFF SERVICES^7^46
 ;;^UTILITY(U,$J,358.4,548,0)
 ;;=ESTABLISHED PATIENT^1^47
 ;;^UTILITY(U,$J,358.4,549,0)
 ;;=CONSULTATIONS^3^47
 ;;^UTILITY(U,$J,358.4,550,0)
 ;;=NEW PATIENT^2^47
 ;;^UTILITY(U,$J,358.4,551,0)
 ;;=POST OP^4^47
 ;;^UTILITY(U,$J,358.4,552,0)
 ;;=ALIMENTARY TRACT^1^48
 ;;^UTILITY(U,$J,358.4,553,0)
 ;;=FRACTURES^2^48
 ;;^UTILITY(U,$J,358.4,554,0)
 ;;=NEOPLASMS^4^48
 ;;^UTILITY(U,$J,358.4,555,0)
 ;;=RESPIRATORY TRACT^6^48
 ;;^UTILITY(U,$J,358.4,556,0)
 ;;=OTOLOGY^5^48
 ;;^UTILITY(U,$J,358.4,557,0)
 ;;=OTHER HEAD AND NECK^7^48
 ;;^UTILITY(U,$J,358.4,558,0)
 ;;=METASTATIC SITES^3^48
 ;;^UTILITY(U,$J,358.4,559,0)
 ;;=NEW PATIENT^3^49
 ;;^UTILITY(U,$J,358.4,560,0)
 ;;=ESTABLISHED PATIENT^2^49
 ;;^UTILITY(U,$J,358.4,561,0)
 ;;=CONSULTS-OUTPATIENT^4^49
 ;;^UTILITY(U,$J,358.4,562,0)
 ;;=EYE CODES^1^49
 ;;^UTILITY(U,$J,358.4,563,0)
 ;;=CONSULTS-INPATIENT^4^49
 ;;^UTILITY(U,$J,358.4,564,0)
 ;;=INITIAL HOSPITAL CARE^5^49
 ;;^UTILITY(U,$J,358.4,565,0)
 ;;=SUBSEQUENT HOSPITAL CARE^6^49
 ;;^UTILITY(U,$J,358.4,566,0)
 ;;=HOSPITAL CARE DISCHARGE^7^49
 ;;^UTILITY(U,$J,358.4,567,0)
 ;;=INITIAL OBSERVATION CARE^8^49
 ;;^UTILITY(U,$J,358.4,568,0)
 ;;=OBSERVATION SUBSEQUENT CARE^9^49
 ;;^UTILITY(U,$J,358.4,569,0)
 ;;=OBSERVATION CARE DISCHARGE SERVICES^10^49
 ;;^UTILITY(U,$J,358.4,570,0)
 ;;=INPT or OBS ADMIT & DISCHARGE SAME DAY^11^49
 ;;^UTILITY(U,$J,358.4,571,0)
 ;;=PROCEDURE-EYELID/LACRIMAL^7^50
 ;;^UTILITY(U,$J,358.4,572,0)
 ;;=PROCEDURE-LASER/CRYO^9^50
 ;;^UTILITY(U,$J,358.4,573,0)
 ;;=PROCEDURE-CORNEA/CONJ^6^50
 ;;^UTILITY(U,$J,358.4,574,0)
 ;;=MEDICATIONS^10^50
 ;;^UTILITY(U,$J,358.4,575,0)
 ;;=PROCEDURE-INJECTIONS^8^50
 ;;^UTILITY(U,$J,358.4,576,0)
 ;;=IMAGING/PHOTOS^2^50
 ;;^UTILITY(U,$J,358.4,577,0)
 ;;=REFRACTION/GLASSES/CL^1^50
 ;;^UTILITY(U,$J,358.4,578,0)
 ;;=TESTING/CATARACT/COLOR^4^50
 ;;^UTILITY(U,$J,358.4,579,0)
 ;;=TESTING/GLAUCOMA^3^50
 ;;^UTILITY(U,$J,358.4,580,0)
 ;;=TESTING/OTHER^5^50
 ;;^UTILITY(U,$J,358.4,581,0)
 ;;=EDUCATION/COUNSELING^11^50
 ;;^UTILITY(U,$J,358.4,582,0)
 ;;=ANTERIOR SEGMENT^2^51
 ;;^UTILITY(U,$J,358.4,583,0)
 ;;=GLAUCOMA^4^51
 ;;^UTILITY(U,$J,358.4,584,0)
 ;;=INFECTIONS^5^51
 ;;^UTILITY(U,$J,358.4,585,0)
 ;;=LENS/CATARACT^6^51
 ;;^UTILITY(U,$J,358.4,586,0)
 ;;=LOW VISION/BLINDNESS^7^51
 ;;^UTILITY(U,$J,358.4,587,0)
 ;;=DIABETES^3^51
 ;;^UTILITY(U,$J,358.4,588,0)
 ;;=MOST COMMON & POST OP^1^51
 ;;^UTILITY(U,$J,358.4,589,0)
 ;;=NEUROLOGIC EYE DISEASE^8^51
 ;;^UTILITY(U,$J,358.4,590,0)
 ;;=ORBIT/EYELID/LACRIMAL^9^51
 ;;^UTILITY(U,$J,358.4,591,0)
 ;;=REFRACTION^10^51
 ;;^UTILITY(U,$J,358.4,592,0)
 ;;=RETINA/VITREOUS^11^51
 ;;^UTILITY(U,$J,358.4,593,0)
 ;;=STRABISMUS^12^51
 ;;^UTILITY(U,$J,358.4,594,0)
 ;;=SYSTEMIC/TRAUMA/OTHER^13^51
 ;;^UTILITY(U,$J,358.4,595,0)
 ;;=REFRACTION/GLASSES/CL^2^52
 ;;^UTILITY(U,$J,358.4,596,0)
 ;;=TESTING/CATARACT/COLOR^3^52
 ;;^UTILITY(U,$J,358.4,597,0)
 ;;=IMAGING/PHOTOS^1^52
 ;;^UTILITY(U,$J,358.4,598,0)
 ;;=TESTING/GLAUCOMA^4^52
 ;;^UTILITY(U,$J,358.4,599,0)
 ;;=TESTING/OTHER^5^52
 ;;^UTILITY(U,$J,358.4,600,0)
 ;;=ANTERIOR SEGMENT^2^53
 ;;^UTILITY(U,$J,358.4,601,0)
 ;;=GLAUCOMA^4^53
 ;;^UTILITY(U,$J,358.4,602,0)
 ;;=INFECTIONS^5^53
 ;;^UTILITY(U,$J,358.4,603,0)
 ;;=LENS/CATARACT^6^53
 ;;^UTILITY(U,$J,358.4,604,0)
 ;;=LOW VISION/BLINDNESS^7^53
 ;;^UTILITY(U,$J,358.4,605,0)
 ;;=DIABETES^3^53
 ;;^UTILITY(U,$J,358.4,606,0)
 ;;=MOST COMMON & POST OP^1^53
 ;;^UTILITY(U,$J,358.4,607,0)
 ;;=NEUROLOGIC EYE DISEASE^8^53
 ;;^UTILITY(U,$J,358.4,608,0)
 ;;=ORBIT/EYELID/LACRIMAL^9^53
 ;;^UTILITY(U,$J,358.4,609,0)
 ;;=REFRACTION^10^53
 ;;^UTILITY(U,$J,358.4,610,0)
 ;;=RETINA/VITREOUS^11^53
 ;;^UTILITY(U,$J,358.4,611,0)
 ;;=STRABISMUS^12^53
 ;;^UTILITY(U,$J,358.4,612,0)
 ;;=SYSTEMIC/TRAUMA/OTHER^13^53
 ;;^UTILITY(U,$J,358.4,613,0)
 ;;=NEW PATIENT^2^54
 ;;^UTILITY(U,$J,358.4,614,0)
 ;;=ESTABLISHED PATIENT^1^54
 ;;^UTILITY(U,$J,358.4,615,0)
 ;;=CONSULTATIONS^3^54
 ;;^UTILITY(U,$J,358.4,616,0)
 ;;=BIOPSY/DEBRIDEMENT^1^55
 ;;^UTILITY(U,$J,358.4,617,0)
 ;;=I&D/ASPIRATION^4^55
 ;;^UTILITY(U,$J,358.4,618,0)
 ;;=DESTRUCT-BENIGN/PREMALIG LESIONS^2^55
 ;;^UTILITY(U,$J,358.4,619,0)
 ;;=SCOPES^7^55
 ;;^UTILITY(U,$J,358.4,620,0)
 ;;=EXCISION^3^55
 ;;^UTILITY(U,$J,358.4,621,0)
 ;;=MISCELLANEOUS^5^55
 ;;^UTILITY(U,$J,358.4,622,0)
 ;;=PEG TUBE^6^55
 ;;^UTILITY(U,$J,358.4,623,0)
 ;;=UNNA BOOT^8^55
 ;;^UTILITY(U,$J,358.4,624,0)
 ;;=WOUND VAC DRESSING^9^55
 ;;^UTILITY(U,$J,358.4,625,0)
 ;;=ABDOMINAL PAIN^1^56
 ;;^UTILITY(U,$J,358.4,626,0)
 ;;=AFTERCARE POST SURGERY^2^56
 ;;^UTILITY(U,$J,358.4,627,0)
 ;;=BENIGN LESIONS OF SKIN^3^56
 ;;^UTILITY(U,$J,358.4,628,0)
 ;;=BREAST-FEMALE^5^56
 ;;^UTILITY(U,$J,358.4,629,0)
 ;;=BREAST-MALE^6^56
 ;;^UTILITY(U,$J,358.4,630,0)
 ;;=CARDIOVASCULAR^7^56
 ;;^UTILITY(U,$J,358.4,631,0)
 ;;=CIRRHOSIS^8^56
 ;;^UTILITY(U,$J,358.4,632,0)
 ;;=COLITIS^9^56
 ;;^UTILITY(U,$J,358.4,633,0)
 ;;=CROHN'S^10^56
 ;;^UTILITY(U,$J,358.4,634,0)
 ;;=DIVERTICULITIS^11^56
 ;;^UTILITY(U,$J,358.4,635,0)
 ;;=DIVERTICULOSIS^12^56
 ;;^UTILITY(U,$J,358.4,636,0)
 ;;=ENT^13^56
 ;;^UTILITY(U,$J,358.4,637,0)
 ;;=GANGLION^14^56
 ;;^UTILITY(U,$J,358.4,638,0)
 ;;=GANGRENE^15^56
 ;;^UTILITY(U,$J,358.4,639,0)
 ;;=GENERAL SIGNS/SYMPTOMS^16^56
 ;;^UTILITY(U,$J,358.4,640,0)
 ;;=GI^17^56
 ;;^UTILITY(U,$J,358.4,641,0)
 ;;=GYN^18^56
 ;;^UTILITY(U,$J,358.4,642,0)
 ;;=HEMORRHOIDS^19^56
 ;;^UTILITY(U,$J,358.4,643,0)
 ;;=INTESTINAL ABSCESS^21^56
 ;;^UTILITY(U,$J,358.4,644,0)
 ;;=LACERATION^22^56
 ;;^UTILITY(U,$J,358.4,645,0)
 ;;=MALIGNANT SKIN LESION^23^56
 ;;^UTILITY(U,$J,358.4,646,0)
 ;;=MELANOMA^24^56
 ;;^UTILITY(U,$J,358.4,647,0)
 ;;=MERKEL CELL CARCINOMA^25^56
 ;;^UTILITY(U,$J,358.4,648,0)
 ;;=OPEN WOUND^26^56
 ;;^UTILITY(U,$J,358.4,649,0)
 ;;=ORTHO^27^56
 ;;^UTILITY(U,$J,358.4,650,0)
 ;;=OTHER INJURY^28^56
 ;;^UTILITY(U,$J,358.4,651,0)
 ;;=PAIN IN EXTREMITIES^29^56
 ;;^UTILITY(U,$J,358.4,652,0)
 ;;=PLASTIC SURGERY^30^56
 ;;^UTILITY(U,$J,358.4,653,0)
 ;;=POSTPROCEDURAL COMPLICATION^31^56
 ;;^UTILITY(U,$J,358.4,654,0)
 ;;=RESPIRATORY^34^56
 ;;^UTILITY(U,$J,358.4,655,0)
 ;;=TRIGGER FINGER^35^56
 ;;^UTILITY(U,$J,358.4,656,0)
 ;;=ULCER^36^56
 ;;^UTILITY(U,$J,358.4,657,0)
 ;;=UROLOGY^37^56
 ;;^UTILITY(U,$J,358.4,658,0)
 ;;=VARICOSE VEINS^38^56
 ;;^UTILITY(U,$J,358.4,659,0)
 ;;=INTRAOPERATIVE COMPLICATIONS^21^56
 ;;^UTILITY(U,$J,358.4,660,0)
 ;;=BITE^4^56
 ;;^UTILITY(U,$J,358.4,661,0)
 ;;=PUNCTURE WOUND^33^56
 ;;^UTILITY(U,$J,358.4,662,0)
 ;;=PREOPERATIVE EXAMS^32^56
 ;;^UTILITY(U,$J,358.4,663,0)
 ;;=HERNIA^20^56
 ;;^UTILITY(U,$J,358.4,664,0)
 ;;=PSYCHOTHERAPY (INPT/OPT/HOME)^5^57
 ;;^UTILITY(U,$J,358.4,665,0)
 ;;=PSYCHOTHERAPY FOR CRISIS^6^57
 ;;^UTILITY(U,$J,358.4,666,0)
 ;;=OTHER CODES^3^57
 ;;^UTILITY(U,$J,358.4,667,0)
 ;;=HLTH/BEHAV ASSESS/INTERVENTION^1^57
 ;;^UTILITY(U,$J,358.4,668,0)
 ;;=TEAM CONFERENCE^8^57
 ;;^UTILITY(U,$J,358.4,669,0)
 ;;=INTERACTIVE COMPLEXITY ADD-ON^2^57
 ;;^UTILITY(U,$J,358.4,670,0)
 ;;=SUBSTANCE USE & MISC SERVICES^7^57
 ;;^UTILITY(U,$J,358.4,671,0)
 ;;=PSYCHIATRIC DIAGNOSTIC EVALUATION^4^57
 ;;^UTILITY(U,$J,358.4,672,0)
 ;;=ABUSE,NEGLECT, & VIOLENCE^1^58
